- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06446232
Influenza Vaccine Effectiveness in Among Young Children in Taiwan
June 5, 2024 updated by: National Taiwan University Hospital
Influenza Vaccine Effectiveness in Inpatient and Outpatient Settings Among Young Children in Taiwan
This project uses questionnaires to statistically analyze whether influenza vaccination is protective for young children.
Study Overview
Status
Recruiting
Conditions
Detailed Description
This plan is expected to admit 350 children who are admitted to the emergency department or hospitalized due to influenza and are aged from 6 months (inclusive) to under 18 years old.
Vaccine status, statistical analysis of whether the flu vaccine is protective.
Study Type
Observational
Enrollment (Estimated)
1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Yi Jen Liau
- Phone Number: 271729 02-23123456
- Email: u8809032@gmail.com
Study Locations
-
-
-
Taipei, Taiwan
- Recruiting
- National Taiwan University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
N/A
Sampling Method
Probability Sample
Study Population
Those who have performed a rapid influenza screening test, regardless of whether the result is negative or positive
Description
Inclusion Criteria:
- Clinical diagnosis of influenza by Flu A+B rapid antigen test
- Known vaccination status
Exclusion Criteria:
- Unknown vaccination status
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Questionnaires
Time Frame: 12 months
|
This project uses questionnaires to statistically analyze whether the flu vaccine is protective for young children.
Researchers collect flu rapid test results and invite subjects to write questionnaires.
Data collectors administered a standardised questionnaire that included information on demographics, medical history (including flu vaccination status and self-reported prior flu infection).
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 1, 2023
Primary Completion (Estimated)
August 31, 2028
Study Completion (Estimated)
August 31, 2029
Study Registration Dates
First Submitted
June 27, 2023
First Submitted That Met QC Criteria
June 5, 2024
First Posted (Actual)
June 6, 2024
Study Record Updates
Last Update Posted (Actual)
June 6, 2024
Last Update Submitted That Met QC Criteria
June 5, 2024
Last Verified
June 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 202304120RINC
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Influenza Vaccine Allergy
-
Universität des SaarlandesFederal Institute of Sport ScienceCompletedInfluenza Virus Vaccine Adverse Reaction | Influenza Vaccine Allergy
-
Centers for Disease Control and Prevention, ChinaCompletedInfluenza Vaccine Allergy | Cell Mediated Reaction
-
Ab&B Bio-tech Co., Ltd.JSYither Biotech Co., LtdActive, not recruitingInfluenza | Influenza VaccineChina
-
Ab&B Bio-tech Co., Ltd.JSYither Biotech Co., LtdActive, not recruitingClinical Trial of Subunit Influenza Vaccine (Adjuvant) in Chinese Population Aged 65 Years and OlderInfluenza | Influenza VaccineChina
-
University of PittsburghMerck Sharp & Dohme LLC; PfizerCompletedAdolescent HPV Vaccine | Adolescent Influenza VaccineUnited States
-
The Jackson LaboratoryNational Institute of Allergy and Infectious Diseases (NIAID); University of... and other collaboratorsActive, not recruitingAging | Influenza Vaccine | Vaccine Response | Dendritic CellUnited States
-
Butantan InstituteUniversity of Sao Paulo; Insituto Adolfo Lutz; Centro de Referencia e Treinamento...CompletedImmunocompromised Patients | Safety of Pandemic Influenza A (H1N1)Vaccine | Immunogenicity of Pandemic Influenza A (H1N1)VaccineBrazil
-
Washington University School of MedicineAstraZenecaRecruitingInfluenza Vaccines | Healthy Young Adults | Influenza Vaccine ResponseUnited States
-
Ab&B Bio-tech Co., Ltd.JSGuangdong Provincial Institute of Biological Products And Materia Medica; Hubei... and other collaboratorsCompletedInfluenza VaccineChina
-
University of Southern CaliforniaUniversity of California, Los Angeles; National Institute on Aging (NIA); Los...Completed